therapeuticЮжно-Российский журнал терапевтической практикиSouth Russian Journal of Therapeutic Practice2712-81563033-8344РостГМУ10.21886/2712-8156-2026-7-1-106-113therapeutic-691Research ArticleКЛИНИЧЕСКИЕ СЛУЧАИCLINICAL CASESСлучай успешного кардиохирургического лечения пациента с недиагностированной акромегалиейA Case of Successful Cardiac Surgery in a Patient with Undiagnosed Acromegaly. South Russian Journal of Therapeutic Practicehttps://orcid.org/0000-0002-3868-8061ТатаринцеваЗ. Г.TatarintsevaZ. G.

Татаринцева Зоя Геннадьевна, к.м.н., заведующая отделением кардиологии; ассистент кафедры кардиохирургии и кардиологии факультета повышения квалификации и профессиональной переподготовки специалистов

Краснодар 

Zoya G. Tatarintseva, Cand. Sci. (Med.), Head of the Department of Cardiology; Assistant of the Department of Cardiac Surgery and Cardiology of the Faculty of Advanced Training and Professional Retraining of Specialists

Krasnodar

z.tatarintseva@list.ruhttps://orcid.org/0009-0009-7334-9928КатушкинаЮ. А.KatushkinaYu. A.

Катушкина Юлия Александровна, врач-эндокринолог эндокринологического отделения; ассистент кафедры терапии №1 факультета повышения квалификации и профессиональной переподготовки специалистов

Краснодар 

Yuliya A. Katushkina, endocrinologist of the endocrinology department; Assistant of the Department of Therapy No. 1 of the Faculty of Advanced Training and Professional Retraining of Specialists

Krasnodar

ukadoc@gmail.comhttps://orcid.org/0000-0002-4866-0345ГоловинаГ. А.GolovinaG. A.

Головина Галина Алексеевна, к.м.н., врач-кардиолог, ассистент кафедры кардиохирургии и кардиологии

Краснодар 

Galina A. Golovina, Cand. Sci. (Med.), cardiologist, assistant of the Department of Cardiac Surgery and Cardiology

Krasnodar

ggolovina.70@mail.ruhttps://orcid.org/0000-0001-5690-2482КосмачеваЕ. Д.KosmachevaE. D.

Космачева Елена Дмитриевна, д.м.н., профессор, заместитель главного врача по лечебной части; заведующая кафедрой терапии №1 ФПК и ППС

Краснодар 

Elena D. Kosmacheva, Dr. Cand. Sci. (Med.), Professor, Deputy Chief Physician for the Medical Department; Head of the Department of Therapy No. 1 of the Faculty of Education and Training

Krasnodar

kosmachova_h@mail.ruГБУЗ «Научно-исследовательский институт – Краевая Клиническая больница № 1 им. проф. С.В. Очаповского» ; ФГБОУ ВО «Кубанский государственный медицинский университет» Минздрава РоссииРоссияResearch Institute – Regional Clinical Hospital No. 1 n. a. Professor S.V. Ochapovsky ; Kuban State Medical UniversityRussian Federation20262703202671106113Copyright © Татаринцева З.Г., Катушкина Ю.А., Головина Г.А., Космачева Е.Д., 20262026Татаринцева З.Г., Катушкина Ю.А., Головина Г.А., Космачева Е.Д.Tatarintseva Z.G., Katushkina Y.A., Golovina G.A., Kosmacheva E.D.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.therapeutic-j.ru/jour/article/view/691

Акромегалия — тяжёлое хроническое нейроэндокринное заболевание, чаще всего встречающееся у взрослых, характеризующееся избытком гормона роста (ГР) и последующим повышением уровня инсулиноподобного фактора роста-1 (ИФР-1). Сердечно-сосудистые осложнения считаются наиболее распространенными осложнениями у пациентов с акромегалией, оказывающие негативное влияние на качество жизни и прогноз. В данной статье представлен случай аневризматического расширения аорты с выраженной аортальной регургитацией у пациента с акромегалией. Пациенту была успешно выполнена операция Бенталла (протезирование аорты и аортального клапана), а через 6 месяцев после кардиохирургического вмешательства проведена транссфеноидальная аденомэктомия без осложнений.

Acromegaly is a severe, chronic neuroendocrine disorder, most commonly occurring in adults, characterized by excess growth hormone (GH) and subsequent elevated insulin-like growth factor-1 (IGF-1) levels. Cardiovascular complications are considered the most common complications in patients with acromegaly, negatively impacting quality of life and prognosis. This article presents a case of aneurysmal aortic dilation with severe aortic regurgitation in a patient with acromegaly. The patient underwent a successful Bentall procedure (aortic and aortic valve replacement), and 6 months after cardiac surgery, transsphenoidal adenomectomy was performed without complications.

акромегалияаневризма восходящей аортыгормон ростаинсулиноподобный фактор роста-1пролапс клапанакардиохирургические операциитранссфеноидальная аденомэктомияacromegalyascending aortic aneurysmgrowth hormoneIGF-1valve prolapsecardiac surgerytranssphenoidal adenomectomyReferencesGiustina A, Barkhoudarian G, Beckers A, Ben-Shlomo A, Biermasz N, Biller B, et al. Multidisciplinary management of acromegaly: A consensus. Rev Endocr Metab Disord. 2020;21(4):667-678. DOI: 10.1007/s11154-020-09588-zGiustina A, Barkhoudarian G, Beckers A, Ben-Shlomo A, Biermasz N, Biller B, et al. Multidisciplinary management of acromegaly: A consensus. Rev Endocr Metab Disord. 2020;21(4):667-678. DOI: 10.1007/s11154-020-09588-zGadelha MR, Kasuki L, Lim DST, Fleseriu M. Systemic Complications of Acromegaly and the Impact of the Current Treatment Landscape: An Update. Endocr Rev. 2019;40(1):268-332. DOI: 10.1210/er.2018-00115Gadelha MR, Kasuki L, Lim DST, Fleseriu M. Systemic Complications of Acromegaly and the Impact of the Current Treatment Landscape: An Update. Endocr Rev. 2019;40(1):268-332. DOI: 10.1210/er.2018-00115Katznelson L, Laws ER Jr, Melmed S, Molitch ME, Murad MH, Utz A, et al. Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99(11):3933-3951. DOI: 10.1210/jc.2014-2700Katznelson L, Laws ER Jr, Melmed S, Molitch ME, Murad MH, Utz A, et al. Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99(11):3933-3951. DOI: 10.1210/jc.2014-2700Burton T, Le Nestour E, Neary M, Ludlam WH. Incidence and prevalence of acromegaly in a large US health plan database. Pituitary. 2016;19(3):262-267. DOI: 10.1007/s11102-015-0701-2Burton T, Le Nestour E, Neary M, Ludlam WH. Incidence and prevalence of acromegaly in a large US health plan database. Pituitary. 2016;19(3):262-267. DOI: 10.1007/s11102-015-0701-2Pivonello R, Auriemma RS, Grasso LF, Pivonello C, Simeoli C, Patalano R, et al. Complications of acromegaly: cardiovascular, respiratory and metabolic comorbidities. Pituitary. 2017;20(1):46-62. DOI: 10.1007/s11102-017-0797-7Pivonello R, Auriemma RS, Grasso LF, Pivonello C, Simeoli C, Patalano R, et al. Complications of acromegaly: cardiovascular, respiratory and metabolic comorbidities. Pituitary. 2017;20(1):46-62. DOI: 10.1007/s11102-017-0797-7Yang H, Tan H, Huang H, Li J. Advances in Research on the Cardiovascular Complications of Acromegaly. Front Oncol. 2021;11:640999. DOI: 10.3389/fonc.2021.640999Yang H, Tan H, Huang H, Li J. Advances in Research on the Cardiovascular Complications of Acromegaly. Front Oncol. 2021;11:640999. DOI: 10.3389/fonc.2021.640999Wu JC, Huang WC, Chang HK, Ko CC, Lirng JF, Chen YC. Natural History of Acromegaly: Incidences, Re-operations, Cancers, and Mortality Rates in a National Cohort. Neuroendocrinology. 2020;110(11-12):977-987. DOI: 10.1159/000505332Wu JC, Huang WC, Chang HK, Ko CC, Lirng JF, Chen YC. Natural History of Acromegaly: Incidences, Re-operations, Cancers, and Mortality Rates in a National Cohort. Neuroendocrinology. 2020;110(11-12):977-987. DOI: 10.1159/000505332Ramos-Leví AM, Marazuela M. Bringing Cardiovascular Comorbidities in Acromegaly to an Update. How Should We Diagnose and Manage Them? Front Endocrinol (Lausanne). 2019;10:120. DOI: 10.3389/fendo.2019.00120Ramos-Leví AM, Marazuela M. Bringing Cardiovascular Comorbidities in Acromegaly to an Update. How Should We Diagnose and Manage Them? Front Endocrinol (Lausanne). 2019;10:120. DOI: 10.3389/fendo.2019.00120Sharma MD, Nguyen AV, Brown S, Robbins RJ. Cardiovascular Disease in Acromegaly. Methodist Debakey Cardiovasc J. 2017;13(2):64-67. DOI: 10.14797/mdcj-13-2-64Sharma MD, Nguyen AV, Brown S, Robbins RJ. Cardiovascular Disease in Acromegaly. Methodist Debakey Cardiovasc J. 2017;13(2):64-67. DOI: 10.14797/mdcj-13-2-64Mosca S, Paolillo S, Colao A, Bossone E, Cittadini A, Iudice FL, et al. Cardiovascular involvement in patients affected by acromegaly: an appraisal. Int J Cardiol. 2013;167(5):1712-1718. DOI: 10.1016/j.ijcard.2012.11.109Mosca S, Paolillo S, Colao A, Bossone E, Cittadini A, Iudice FL, et al. Cardiovascular involvement in patients affected by acromegaly: an appraisal. Int J Cardiol. 2013;167(5):1712-1718. DOI: 10.1016/j.ijcard.2012.11.109Gharoy H, Taghavi S, Ghaemmaghami Z, Rabiei P, Afzalnia A. Aneurysmal dilation of sinus of Valsalva in a patient with undiagnosed acromegaly. Clin Case Rep. 2023;11(12):e8326. DOI: 10.1002/ccr3.8326Gharoy H, Taghavi S, Ghaemmaghami Z, Rabiei P, Afzalnia A. Aneurysmal dilation of sinus of Valsalva in a patient with undiagnosed acromegaly. Clin Case Rep. 2023;11(12):e8326. DOI: 10.1002/ccr3.8326Белая Ж.Е., Голоунина О.О., Рожинская Л.Я., Мельниченко Г.А., Исаков М.А., Луценко А.С., и др. Эпидемиология, клинические проявления и эффективность различных методов лечения акромегалии по данным единого российского регистра опухолей гипоталамо-гипофизарной системы. Проблемы Эндокринологии. 2020;66(1):93-103. DOI: 10.14341/probl10333Belaya Zh.E., Golounina O.O., Rozhinskaya L.Y., Melnichenko G.A., Isakov M.А., Lutsenko A.S., et al. Epidemiology, clinical manifestations and efficiency of different methods of treatment of acromegaly according to the United Russian Registry of Patients with Pituitary Tumors. Problems of Endocrinology. 2020;66(1):93-103. (In Russ.) DOI: 10.14341/probl10333Faje AT, Barkan AL. Basal, but not pulsatile, growth hormone secretion determines the ambient circulating levels of insulin-like growth factor-I. J Clin Endocrinol Metab. 2010;95(5):2486-2491. DOI: 10.1210/jc.2009-2634Faje AT, Barkan AL. Basal, but not pulsatile, growth hormone secretion determines the ambient circulating levels of insulin-like growth factor-I. J Clin Endocrinol Metab. 2010;95(5):2486-2491. DOI: 10.1210/jc.2009-2634Giustina A, Chanson P, Kleinberg D, Bronstein MD, Clemmons DR, Klibanski A, et al. Expert consensus document: A consensus on the medical treatment of acromegaly. Nat Rev Endocrinol. 2014;10(4):243-248. DOI: 10.1038/nrendo.2014.21Giustina A, Chanson P, Kleinberg D, Bronstein MD, Clemmons DR, Klibanski A, et al. Expert consensus document: A consensus on the medical treatment of acromegaly. Nat Rev Endocrinol. 2014;10(4):243-248. DOI: 10.1038/nrendo.2014.21Famini P, Maya MM, Melmed S. Pituitary magnetic resonance imaging for sellar and parasellar masses: ten-year experience in 2598 patients. J Clin Endocrinol Metab. 2011;96(6):1633-1641. DOI: 10.1210/jc.2011-0168Famini P, Maya MM, Melmed S. Pituitary magnetic resonance imaging for sellar and parasellar masses: ten-year experience in 2598 patients. J Clin Endocrinol Metab. 2011;96(6):1633-1641. DOI: 10.1210/jc.2011-0168Lavrentaki A, Paluzzi A, Wass JA, Karavitaki N. Epidemiology of acromegaly: review of population studies. Pituitary. 2017;20(1):4-9. DOI: 10.1007/s11102-016-0754-xLavrentaki A, Paluzzi A, Wass JA, Karavitaki N. Epidemiology of acromegaly: review of population studies. Pituitary. 2017;20(1):4-9. DOI: 10.1007/s11102-016-0754-xYang C, Li G, Jiang S, Bao X, Wang R. Preoperative Somatostatin Analogues in Patients with Newly-diagnosed Acromegaly: A Systematic Review and Meta-analysis of Comparative Studies. Sci Rep. 2019;9(1):14070. DOI: 10.1038/s41598-019-50639-6Yang C, Li G, Jiang S, Bao X, Wang R. Preoperative Somatostatin Analogues in Patients with Newly-diagnosed Acromegaly: A Systematic Review and Meta-analysis of Comparative Studies. Sci Rep. 2019;9(1):14070. DOI: 10.1038/s41598-019-50639-6Albarel F, Cuny T, Graillon T, Dufour H, Brue T, Castinetti F. Preoperative Medical Treatment for Patients With Acromegaly: Yes or No? J Endocr Soc. 2022;6(9):bvac114. DOI: 10.1210/jendso/bvac114Albarel F, Cuny T, Graillon T, Dufour H, Brue T, Castinetti F. Preoperative Medical Treatment for Patients With Acromegaly: Yes or No? J Endocr Soc. 2022;6(9):bvac114. DOI: 10.1210/jendso/bvac114

The authors declare that there are no conflicts of interest present.